Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | PRKCB | P05771 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17406375 | 0.94 | GAA (0.33) | GAAMAPTMAPK1HTTHSD17B10 | |
| SCHEMBL17406131 | 0.93 | GAA (0.33) | GAAMAPTMAPK1HTTHSD17B10 | |
| SCHEMBL17405572 | 0.93 | GAA (0.33) | GAAMAPTMAPK1HTTHSD17B10 | |
| SCHEMBL16275850 | 0.93 | GAA (0.33) | GAAMAPTMAPK1HTTHSD17B10 | |
| SCHEMBL17405419 | 0.91 | GAA (0.33) | GAAMAPTMAPK1HTTHSD17B10 | |
| SCHEMBL16275495 | 0.91 | GAA (0.33) | GAAMAPTMAPK1HTTHSD17B10 | |
| SCHEMBL17406449 | 0.91 | DUSP3 (0.30) | — | |
| SCHEMBL17405937 | 0.90 | GAA (0.33) | GAAMAPTMAPK1HTTHSD17B10 | |
| SCHEMBL17406441 | 0.89 | ATM (0.33) | GAAMAPTHSD17B10 | |
| SCHEMBL17406289 | 0.86 | HTT (0.38) | GAAMAPTMAPK1HTTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9887367-B2 | Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-06 | — | — | US | disclosed |
| US-9887367-B2 | Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-06 | — | — | US | disclosed |
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160005977-A1 | HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | ODC1, NOTUM, OR10J3 | GAA 2846/4885MAPT 2869/4885MAPK1 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.